Table 4 Bivariate logistic regression analysis of factors associated with hyperuricemia among non-dialysis CKD patients, Gondar, Ethiopia, 2024 (n = 189).

From: Prevalence and associated factors of hyperuricemia in chronic kidney disease: evidence from a single-center hospital-based study in Ethiopia, 2024

Variable

Category

Normal UA (n)

Hyperuricemia (n)

COR (95% CI)

p-value

Sex

Female

38

51

1.00

Male

27

73

2.05 (1.10–3.82)

0.023

BMI (kg/m2)

18.5–24.9

44

50

1.00

< 18.5

5

3

0.50 (0.12–2.20)

0.360

25–29.9

12

53

3.90 (1.85–8.20)

< 0.001

≥ 30

4

18

3.30 (1.25–8.65)

0.015

eGFR (mL/min/1.73 m2)

≥ 45

27

18

1.00

30–44

17

22

1.95 (0.80–4.65)

0.130

15–29

15

58

5.20 (2.20–12.3)

< 0.001

< 15 (non-dialysis)

6

26

6.00 (2.35–15.4)

< 0.001

Proteinuria (g/day)

< 0.5

33

47

1.00

0.5–3.5

21

41

1.25 (0.65–2.45)

0.510

≥ 3.5

11

36

1.95 (0.95–4.05)

0.070

Triglyceride (mg/dL)

< 150

43

57

1.00

≥ 150

22

67

2.60 (1.40–4.90)

0.002

Total cholesterol (mg/dL)

< 220

49

87

1.00

≥ 220

16

37

1.50 (0.75–2.90)

0.210

Smoking

Non-smoker

59

109

1.00

Ex-smoker

4

9

1.40 (0.45–4.25)

0.510

Current smoker

2

6

2.40 (0.60–9.50)

0.190

Comorbidity

No

21

34

1.00

Yes

44

90

0.70 (0.35–1.35)

0.240

  1. BMI body mass index, COR crude odds ratio, CI confidence interval, eGFR estimated glomerular filtration rate, mg/dL milligrams per deciliter, TG triglyceride.